-
Mashup Score: 1Program Guide – ASCO Meeting Program Guide - 9 day(s) ago
Justin Miller , Alyssa Obermayer , Mitchell Hayes , Roy Elias , Nirmish Singla , Michelle Churchman , George Grass , Ahmad Tarhini , Paola Ramos Echevarria , Alex Soupir , Youngchul Kim , Eric Singer , Sean Kern , Yousef Zakharia , Paul Viscuse , Patrick Hensley , Timothy Shaw , Brandon Manley USF Health Morsani College of Medicine, H. Lee Moffitt Cancer Center and Research Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, James Buchanan Brady Urological Institute, Johns Hopkins
Source: meetings.asco.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Program Guide – ASCO Meeting Program Guide - 9 day(s) ago
Adnan Fazili H. Lee Moffitt Cancer Center and Research Institute Adnan Fazili , Keerthi Gullapalli , Jasreman Dhillon , Carlos Segura , Jonathan Nguyen , Youngchul Kim , Junmin Whiting , Justin Miller , Christopher Guske , Hiroko Miyagi , Jeffrey Johnson , Logan Zemp , Philippe Spiess , Jad Chahoud H. Lee Moffitt Cancer Center and Research Institute, H. Lee Moffitt Cancer Center and Research Institute/University of South Florida Morsani, Moffitt Cancer Center, University of South Florida Morsani College
Source: meetings.asco.orgCategories: General Medicine News, Oncologists1Tweet-
Join Adnan Fazili, MD tomorrow at ASCO #GU25 as he presents on using geospatial analysis with multiplex immunofluorescence to analyze tumor immune microenvironment patterns and prognosis in penile cancer. Read more: https://t.co/QkehkmqwFj @ASCO https://t.co/M5aMWaaeAv
-
-
Mashup Score: 1Program Guide – ASCO Meeting Program Guide - 9 day(s) ago
Adnan Fazili H. Lee Moffitt Cancer Center and Research Institute Adnan Fazili , Brian Morse , Abraham Ahmed , Jongphil Kim , Daniel Jeong , Philippe Spiess , Jad Chahoud H. Lee Moffitt Cancer Center and Research Institute, H. Lee Moffitt Cancer Center & Research Institute, Moffitt Cancer Center, Department of Genitourinary Medical Oncology, H. Lee Moffitt Cancer Center and R esearch Institute The risk level of lymph node metastasis in penile cancer is determined using the Graafland criteria which determine
Source: meetings.asco.orgCategories: General Medicine News, Oncologists1Tweet-
Tomorrow at ASCO #GU25, Adnan Fazili, MD, presents the application of radiomics as a risk stratification tool in node-positive penile cancer. Learn more: https://t.co/KfVryhOtT7 @ASCO https://t.co/VW2O8IWj0e
-
-
Mashup Score: 0Program Guide – ASCO Meeting Program Guide - 9 day(s) ago
Hiroko Miyagi H. Lee Moffitt Cancer Center and Research Institute Hiroko Miyagi , Xiaoqing Yu , Taylor Peak , Jasreman Dhillon , Casey Le , Xuefeng Wang , Sean Yoder , Douglas Marchion , Xin Lu , Curtis Pettaway , Carlos Segura , Gabriel Roman Souza , Alice Yu , Chaomei Zhang , Logan Zemp , Philippe Spiess , Jad Chahoud H. Lee Moffitt Cancer Center and Research Institute, Moffitt Cancer Center, University of Notre Dame, Division of Surgery, Department of Urology, The University of Texas MD Anderson
Source: meetings.asco.orgCategories: General Medicine News, Oncologists1Tweet-
Join Hiroko Miyagi, MD, tomorrow at ASCO #GU25 as she presents on progressive T cell exhaustion and the predominance of aging tissue-associated macrophages with advancing disease stage in penile squamous cell carcinoma. Learn more: https://t.co/gu6sxTB723 @ASCO https://t.co/GP6D0oCYFp
-
-
Mashup Score: 0Program Guide – ASCO Meeting Program Guide - 9 day(s) ago
Jeffrey Johnson H. Lee Moffitt Cancer Center, Department of Hematology/Oncology Jeffrey Johnson , Mayer Fishman , Michael Schell , Xiaoqing Yu , Xuefeng Wang , Gabriel Roman Souza , Justin Miller , Sarah Mizelle , Keerthi Gullapalli , Adnan Fazili , Christopher Guske , Gowtam Mannam , Ghazal Jameel , Ling Cen , Jiqiang Yao , Junmin Whiting , Jennifer Swank , Jingsong Zhang , Philippe Spiess , Jad Chahoud H. Lee Moffitt Cancer Center, Department of Hematology/Oncology, Tampa, General Hospital Cancer
Source: meetings.asco.orgCategories: General Medicine News, Oncologists1Tweet-
Tomorrow at ASCO #GU25: Jeffrey Johnson, MD presents an updated efficacy, safety, and correlative analysis of a phase II trial in metastatic renal cell carcinoma with coordinated pembrolizumab and high dose IL-2. Read more: https://t.co/z2X0IOaJ4N @ASCO https://t.co/icEmOKNlRR
-
-
Mashup Score: 6Program Guide – ASCO Meeting Program Guide - 9 day(s) ago
Ruben Raychaudhuri , Ali Khaki , Mary Redman , Kelsey Baker , Aaron Lin , Brianna Woo , Andrii Hannochka , Nathan Conrad , Funda Vakar-Lopez , Todd Yezefski , Michael Schweizer , Robert Montgomery , Evan Yu , Atreya Dash , Sarah Psutka , Daniel Lin , George Schade , John Gore , Jonathan Wright , Petros Grivas University of Washington & Fred Hutchinson Cancer Center, Stanford University, Fred Hutchinson Cancer Center, Department of Pathology, University of Washington, Department of Urology, University of
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#769 @ASCO #GU25 👉Congrats @RubenRaychaud @PGrivasMDPhD👉https://t.co/SCnL1Y04hU👉Ph2 trial of neoadj pembro + aMVAC in pts w/ non-urothelial MIBC #bladdercancer👉pCR 53%, median EFS 38 mos & median OS NR👉Promising data👇 @OncoAlert @urotoday @BladdercancerUS https://t.co/KjNMGSYb1Z
-
-
Mashup Score: 61Program Guide – ASCO Meeting Program Guide - 10 day(s) ago
Arun Azad Department of Medical Oncology, Peter MacCallum Cancer Centre Arun Azad , Ding-Wei Ye , Hiroji Uemura , Amitabha Bhaumik , Michael Eisbacher , Anildeep Singh , Sharon McCarthy , Suneel Dinkar Mundle , Kim Chi , Neeraj Agarwal Department of Medical Oncology, Peter MacCallum Cancer Centre, Fudan University Shanghai Cancer Center, Yokohama City University Medical Center, Johnson & Johnson Research and Development, Johnson & Johnson – Australia and New Zealand, Johnson & Johnson, University of
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#165 @ASCO #GU25 by @AzadOncology👉https://t.co/CssaQq8peS👉In ph3 TITAN trial in pts w/ mHSPC #prostatecancer👉rPFS & OS improved w/ ADT+APA regardless of prior CV/metabolic baseline risk or concomitant meds👇@Huntsman_GU @OncoAlert @urotoday @PCF_Science https://t.co/fuHZPGW9Nt
-
-
Mashup Score: 42Program Guide – ASCO Meeting Program Guide - 10 day(s) ago
Laurence Albiges Gustave Roussy, Paris-Saclay University Laurence Albiges , Cristina Suárez , Thomas Powles , Robert Motzer , Walter Stadler , Wilson Miller Jr., Carlos Rojas , Avivit Peer , Jeffrey Goh , Se Hoon Park , Tom Waddell , Philippe Barthelemy , Pablo Gajate , Andrew Weickhardt , Guy Faust , Rodolfo Perini , Lockman Bousserouel , Ding Wang , Hans Hammers , Katy Beckermann Gustave Roussy, Paris-Saclay University, Vall d’Hebron Institute of Oncology, Hospital Univer sitari Vall d’Hebron, Vall
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#440 @ASCO #GU25 by @AlbigesL👉https://t.co/EdYbRxWxgQ👉Results of ph1 KEYMAKER-U03 #kidneycancer👉Lenvatinib + belzutifan showed durable antitumor activity w/ ORR 47% in mRCC s/p VEGF-TKI+IO👇@katy_beckermann @OncoAlert @urotoday @KidneyCancer @Uromigos https://t.co/rjGxmzPbn2
-
-
Mashup Score: 2Program Guide – ASCO Meeting Program Guide - 10 day(s) ago
The abstract will be released to the public on February 13, 2025 at 3:00 PM UTC Neeraj Agarwal , Arun Azad , Joan Carles , Andre Fay , Nobuaki Matsubara , Cezary Szczylik , Ugo De Giorgi , Jae Young Joung , Peter Fong , Eric Voog , Robert Jones , Neal Shore , Curtis Dunshee , Stefanie Zschaebitz , Jan Oldenburg , Xun Lin , Cynthia Healy , Matko Kalac , Dana Kennedy , Karim Fizazi Huntsman Cancer Institute at the University of Utah, Peter MacCallum Cancer Centre, Vall d’Hebron University Hospital, Vall
Source: meetings.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
In our latest “Science in Seconds” Dr. @BradMcG04 discusses 2 abstracts findings from phase 3 TALAPRO-2 trial highlighting final OS w TALA + ENZA as 1st-line Tx: 1 for unselected pts w #mCRPC & 1 for pts w HRR-deficient mCRPC. #GI25 https://t.co/cBp0UUMdvJ https://t.co/zBGxdeQyrI https://t.co/eYuGqImlQV
-
-
Mashup Score: 32Program Guide – ASCO Meeting Program Guide - 10 day(s) ago
The abstract will be released to the public on February 13, 2025 at 3:00 PM UTC Neeraj Agarwal , Arun Azad , Joan Carles , Andre Fay , Nobuaki Matsubara , Cezary Szczylik , Ugo De Giorgi , Jae Young Joung , Peter Fong , Eric Voog , Robert Jones , Neal Shore , Curtis Dunshee , Stefanie Zschaebitz , Jan Oldenburg , Xun Lin , Cynthia Healy , Matko Kalac , Dana Kennedy , Karim Fizazi Huntsman Cancer Institute at the University of Utah, Peter MacCallum Cancer Centre, Vall d’Hebron University Hospital, Vall
Source: meetings.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
In our latest “Science in Seconds” Dr. @BradMcG04 discusses 2 abstracts findings from phase 3 TALAPRO-2 trial highlighting final OS w TALA + ENZA as 1st-line Tx: 1 for unselected pts w #mCRPC & 1 for pts w HRR-deficient mCRPC. #GI25 https://t.co/cBp0UUMdvJ https://t.co/zBGxdeQyrI https://t.co/eYuGqImlQV
-
Join Justin Miller (@JMillerMed) tomorrow at ASCO #GU25 as he presents FGD1 splice variants as predictors of brain and bone metastatic organotropism in clear cell renal cell carcinoma. Read more: https://t.co/H8fmN92Iq9 @ASCO https://t.co/qrScUSYzjq